Literature DB >> 33426160

Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak.

Rosa De Micco1, Mattia Siciliano1,2, Valeria Sant'Elia1,2, Alfonso Giordano1, Antonio Russo1, Gioacchino Tedeschi1, Alessandro Tessitore1.   

Abstract

BACKGROUND: Following the severe consequences of the COVID-19 outbreak, on March 9, 2020, the Italian government implemented extraordinary measures to limit viral transmission, including restrictive quarantine measures. This resulted in a rapid and profound change of people's daily lives.
OBJECTIVE: We assessed the psychological impact of the 40-day quarantine in a large cohort of patients with Parkinson's disease (PD) and caregivers. Moreover, we analyzed whether prelockdown clinical features may be associated with subjective response of patients with PD to this traumatic event.
METHODS: A total of 94 patients with PD were enrolled in the study. The Impact of Event Scale-Revised, the Kessler Psychological Distress Scale, and the 12-item Zarit Burden Inventory were obtained from patients and caregivers by email. A multivariate regression analysis was performed to determine whether prelockdown clinical motor and nonmotor features were associated with the psychological impact of lockdown.
RESULTS: Regression analyses showed that prelockdown levels of anxiety, treatment-related motor complications, patients' quality of life, and lockdown hours per day were significantly associated with psychological impact measures of the 40-day quarantine. In addition, we showed that caregiver burden was correlated with overall patient autonomy and attention/memory impairment.
CONCLUSIONS: We identified specific PD motor and nonmotor features potentially predisposing to higher psychological impact of stressful situations, such as quarantine. This may help guide postpandemic interventions and preventive strategies to avoid further impairment of psychological well-being in patients with PD.
© 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  COVID‐19; Parkinson's disease; anxiety; quality of life; stress

Year:  2020        PMID: 33426160      PMCID: PMC7780948          DOI: 10.1002/mdc3.13108

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  42 in total

1.  The Parkinson fatigue scale.

Authors:  R G Brown; A Dittner; L Findley; S C Wessely
Journal:  Parkinsonism Relat Disord       Date:  2005-01       Impact factor: 4.891

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.

Authors:  Albert F G Leentjens; Kathy Dujardin; Gregory M Pontone; Sergio E Starkstein; Daniel Weintraub; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2014-05-23       Impact factor: 10.338

4.  Factors influencing compliance with quarantine in Toronto during the 2003 SARS outbreak.

Authors:  Clete DiGiovanni; Jerome Conley; Daniel Chiu; Jason Zaborski
Journal:  Biosecur Bioterror       Date:  2004

5.  Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain.

Authors:  Jennifer M Wenzel; Erik B Oleson; Willard N Gove; Anthony B Cole; Utsav Gyawali; Hannah M Dantrassy; Rebecca J Bluett; Dilyan I Dryanovski; Garret D Stuber; Karl Deisseroth; Brian N Mathur; Sachin Patel; Carl R Lupica; Joseph F Cheer
Journal:  Curr Biol       Date:  2018-04-19       Impact factor: 10.834

6.  Movement Disorders in the World of COVID-19.

Authors:  A Jon Stoessl; Kailash P Bhatia; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-04-16

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 8.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

9.  The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.

Authors:  Peter Hagell; Carita Nygren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

10.  Predictors of motor complications in early Parkinson's disease: A prospective cohort study.

Authors:  Mark J Kelly; Michael A Lawton; Fahd Baig; Claudio Ruffmann; Thomas R Barber; Christine Lo; Johannes C Klein; Yoav Ben-Shlomo; Michele T Hu
Journal:  Mov Disord       Date:  2019-07-08       Impact factor: 10.338

View more
  7 in total

1.  Spotlight on non-motor symptoms and Covid-19.

Authors:  Silvia Rota; Iro Boura; Yi-Min Wan; Claudia Lazcano-Ocampo; Mayela Rodriguez-Violante; Angelo Antonini; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-07-09       Impact factor: 4.280

Review 2.  Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review.

Authors:  Fardin Nabizadeh; Zahrasadat Seyedalhosseini; Mohammad Balabandian; Mohammad Reza Rostami
Journal:  J Clin Neurosci       Date:  2022-06-28       Impact factor: 2.116

3.  Psychological impact of COVID-19 pandemic on Parkinson's disease patients.

Authors:  Muhammad Tufail; Changxin Wu
Journal:  Heliyon       Date:  2022-06-03

4.  A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease.

Authors:  Alfonsina D'Iorio; Chiara Baiano; Giovanna Maraucci; Carmine Vitale; Marianna Amboni; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2022-05-10       Impact factor: 3.830

Review 5.  Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review.

Authors:  S K Brooks; D Weston; N Greenberg
Journal:  Public Health       Date:  2021-09-01       Impact factor: 4.984

6.  Deriving Implications for Care Delivery in Parkinson's Disease by Co-Diagnosing Caregivers as Invisible Patients.

Authors:  Franziska Thieken; Marlena van Munster
Journal:  Brain Sci       Date:  2021-12-10

Review 7.  Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research.

Authors:  B Y Valdovinos; J S Modica; R B Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.